Evidence map›Paper›PMID 37746799›Full record

ArticleClinical and translational allergy2023

Novel, computational IgE-clustering in a population-based cross-sectional study: Mapping the allergy burden.

Rebecca Czolk, Maria Ruiz-Castell, Oliver Hunewald, Naphisabet Wanniang, Gwenaëlle Le Coroller, Christiane Hilger, Michel Vaillant, Guy Fagherazzi, Françoise Morel-Codreanu, Markus Ollert and 1 more

Open access · goldAbstract read
In one paragraph

Article in Clinical and translational allergy, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.7field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 4 institutions in 2 countries.

Rebecca CzolkDepartment of Infection and Immunity, Luxembourg Institute of Health, Esch-sur-Alzette, Luxembourg.
Maria Ruiz-CastellEpidemiology and Public Health Research Unit, Department of Precision Health, Luxembourg Institute of Health, Strassen, Luxembourg.
Oliver HunewaldDepartment of Infection and Immunity, Luxembourg Institute of Health, Esch-sur-Alzette, Luxembourg.
Naphisabet WanniangDepartment of Infection and Immunity, Luxembourg Institute of Health, Esch-sur-Alzette, Luxembourg.
Gwenaëlle Le CorollerCompetence Center for Methodology and Statistics, Translational Medicine Operations Hub, Luxembourg Institute of Health, Strassen, Luxembourg.
Christiane HilgerDepartment of Infection and Immunity, Luxembourg Institute of Health, Esch-sur-Alzette, Luxembourg.
Michel VaillantCompetence Center for Methodology and Statistics, Translational Medicine Operations Hub, Luxembourg Institute of Health, Strassen, Luxembourg.
Guy FagherazziEpidemiology and Public Health Research Unit, Department of Precision Health, Luxembourg Institute of Health, Strassen, Luxembourg.
Françoise Morel-CodreanuDepartment of Allergology and Immunology, Centre Hospitalier de Luxembourg-Kanner Klinik, Luxembourg, Luxembourg.
Markus OllertDepartment of Infection and Immunity, Luxembourg Institute of Health, Esch-sur-Alzette, Luxembourg.
Annette KuehnDepartment of Infection and Immunity, Luxembourg Institute of Health, Esch-sur-Alzette, Luxembourg.ORCID https://orcid.org/0000-0003-0474-2135
Luxembourg Institute of Health · LUUniversity of Luxembourg · LUCentre Hospitalier de Luxembourg · LUUniversity of Southern Denmark · DK

Funding

Fonds National de la Recherche Luxembourg PRIDE17/11823097/MICROHFonds National de la Recherche Luxembourg PRIDE i2TRON PRIDE19/14254520Ministère de la Santé LuxembourgMinistère de l'Enseignement Supérieur et de la Recherche
6 · The paper itself

Abstract

backgroundEven though the prevalence of allergies is increasing, population-based data are still scarce. As a read-out for chronic inflammatory information, new methods are needed to integrate individual biological measurements and lifestyle parameters to mitigate the consequences and costs of allergic burden for society.

methodsMore than 480.000 data points were collected from 1462 Luxembourg adults during the representative, cross-sectional European Health Examination Survey, spanning health and lifestyle reports. Deep IgE-profiles based on unsupervised clustering were correlated with data of the health survey.

findings42.6% of the participants reported a physician-diagnosed allergy and 44% were found to be IgE-positive to at least one allergen or extract. The main sensitization sources were tree pollens followed by grass pollens and mites (52.4%, 51.8% and 40.3% of sensitized participants respectively), suggesting seasonal as well as perennial burden. The youngest group of participants (25-34 years old) showed the highest burden of sensitization, with 18.2% of them having IgE to 10 or more allergen groups. Unsupervised clustering revealed that the biggest cluster of 24.4% of participants was also the one with the highest medical need, marked by their multi-sensitization to respiratory sources.

interpretationOur novel approach to analyzing large biosample datasets together with health information allows the measurement of the chronic inflammatory disease burden in the general population and led to the identification of the most vulnerable groups in need of better medical care.

Indexed as

allergy burdenEuropean Health Examination Surveymultiplex IgE-profilespopulation-based cross-sectional study

Identifiers

PMID37746799
PMCPMC10478827
OpenAlexW4386461272

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.